TruAlt BioenergyQ1 FY27
TruAlt Bioenergy Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹438P/E: 24.5Market Cap: ₹3.8K CrSector: Agricultural Food & other Products
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
- →TruAlt Bioenergy expects to increase ethanol capacity utilization from current ~60% to 80-90% in upcoming quarters, with Q2 FY27 sales projected at around 11 crore litres (Page 22).
- →The company has 44 crore litres of ethanol orders on hand for FY27, expecting volumes higher than last year's 40 crore litres (Page 8).
- →No further capex planned in ethanol segment; focus on utilizing existing capacity fully (Page 7).
- →CBG revenues to begin from Q4 FY27 with ongoing capex of ~INR700 crores, expanding compressed biogas business (Page 7).
- →SAF (Sustainable Aviation Fuel) business involves a planned INR2,000 crore capex with revenues anticipated starting FY29, expected asset turnover of 1x (Page 7).
- →Potential growth if ethanol blending percentage increases beyond 20% (Page 24).
- →No new ethanol capacity additions expected across the industry, except a few plants yet to commission adding 8-10 crore litres per annum (Page 24).
Margin guidance
- →The company expects to increase ethanol production and improve capacity utilization from the current 60% to around 80-90%, which should boost revenues and profits in upcoming quarters.
- →For FY27, ethanol sales target is at least 44 crore litres, potentially more depending on policy and market conditions.
- →CBG business expects sustained EBITDA >60% and PAT margins of 40-50%, with new plants starting to contribute by Q4 FY27 due to ongoing capex with partners Sumitomo and GAIL.
- →The planned SAF (Sustainable Aviation Fuel) plant capex of about INR 2,000 crores is expected to begin generating revenue by FY29, having an estimated asset turn of 1x and margin profiles of around 24-25%.
- →Efforts on raw material procurement at lower prices and dual feedstock usage are expected to improve margins further.
- →Plans to deleverage the balance sheet are underway, which could improve net earnings and shareholder confidence.
- →Overall, firm expects growth in earnings, operating profits, and EPS driven by capacity ramp-up, diversification, and new product lines.
3 more insights locked — sign up free to unlock
Fundraise plans
- →The company has plans to de-lever its balance sheet and reduce finance costs, with potential announcements expected in the next call or few days (Page 23).
- →There is no explicit mention of immediate new fundraising through equity or debt in the ethanol segment.
- →Shareholder queries about fundraising or equity issuance for de-leveraging were acknowledged; management is working on plans but no concrete action disclosed yet (Page 23).
- →Existing capital expenditure is underway for CBG and SAF businesses with equity and debt partnerships (51% holding with partners, funded on approx. 70:30 debt-to-equity), but no independent fresh fundraising specified (Page 16, 7).
- →Management is focusing on improving capacity utilization and operational metrics rather than new investments in the ethanol segment currently (Page 24).
- →Advertisement and strategic partnerships are being planned but do not mention new fundraising rounds immediately (Page 22).
Order book
- →TruAlt Bioenergy currently has an order book of approximately 44 crore litres of ethanol for FY2027.
- →This includes orders from Oil Marketing Companies (OMCs), private sector, and ENA sales.
- →In Q1 FY27, they sold about 8.29 crore litres and expect around 11 crore litres of sales in Q2 FY27, indicating a strong pipeline.
- →There is an ongoing 15 crore litre spillover order from the previous period, currently under discussions with OMCs, expected to be realized soon.
- →The company aims to increase capacity utilization from current ~60% toward 90-95% to fulfill higher orders.
- →No significant new capacity additions are planned in ethanol; growth will come from better capacity utilization and existing pending orders.
Capex plans
- →No further capex planned in the ethanol segment as all capacities are commissioned and ready for utilization.
- →INR ~700 crores capex underway in the CBG segment through two JVs:
- → - INR 330 crores for four 20 TPD CBG plants with Sumitomo.
- → - INR 425 crores for six 10 TPD CBG plants with GAIL.
- →CBG capex funded at 70:30 debt-to-equity; TruAlt holds 51% stake.
- →INR ~2,000 crores capex planned for Sustainable Aviation Fuel (SAF) production, with EPC contract awards awaited.
- →SAF capex expected to start within 2-3 months, with revenues anticipated by FY29 (end 2028).
- →No new capacity additions expected in ethanol; growth expected from increased utilization and existing plants.
- →Technology tie-up with Indian Institute of Science for biomass oxy-steam gasification for green hydrogen, but no progress due to lack of market/supply chain.
How does TruAlt Bioenergy rank vs peers in Agricultural Food & other Products?
Pro feature1TruAlt Bioenergy
See full Agricultural Food & other Products sector rankings
How does TruAlt Bioenergy rank in Agricultural Food & other Products?
Compare TruAlt Bioenergy against every Agricultural Food & other Products company (Q1 FY27) on revenue, margins and earnings-call signals.